Acta Biochimica et Biophysica Sinica · 2011 · 18 citations · 13 references
Breast OncologyNeogambogic AcidChemoprevention StrategyApoptosisCell DeathAnticancer EffectTumor BiologyOxidative StressAnti-cancer AgentCell SignalingCancer ResearchMedicinePharmacologyCell BiologyTumor MicroenvironmentMcf-7 CellsHuman Mcf-7 CellsBreast CancerTumor SuppressorOncology
Neogambogic acid (NGA), an active ingredient in garcinia, can inhibit the growth of some solid tumors and result in an anticancer effect. We hypothesize that NGA may be responsible for the inhibition of proliferation of human breast cancer cell line MCF-7 cells. To investigate its anticancer mechanism in vitro, MCF-7 cells were treated with various concentrations of NGA. Results of MTT (methyl thiazolyl tetrazolum) assay showed that treatment with NGA significantly reduced the proliferation of MCF-7 cells in a dose-dependent manner. NGA could increase the expression of the apoptosis-related proteins FasL, caspase-3, caspase-8, caspase-9, and Bax and decrease the expression of anti-apoptotic protein Bcl-2 accompanied by the mitochondrial transmembrane damage. The antiproliferative effect of NGA on MCF-7 cells is due to the G(0)/G(1) arrest, increased apoptosis and activation of Fas/FasL and cytochrome C pathway. These results provide an important insight into the cellular and molecular mechanisms through which NGA impairs the proliferation of breast cancer cells.
13
Ahmedin Jemal, Rebecca L. Siegel, Jiaquan Xu et al. · CA A Cancer Journal for Clinicians · 2010 · 12.6K citations · Full text
Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species
Darci J. Kane, Theodore A. Sarafian, Rein Anton et al. · Science · 1993 · 1.7K citations
Neural Death, Apoptosis, Immunology +21
Connected to Death: The (Unexpurgated) Mitochondrial Pathway of Apoptosis
Diana C.J. Spierings, Gavin P. McStay, Maya Saleh et al. · Science · 2005 · 292 citations